Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34.
暂无分享,去创建一个
H. Genant | D. Miao | H. Kronenberg | N. Amizuka | D. Goltzman | A. Karaplis | Yebin Jiang | Tatsuya Kobayashi | Jenny Zhao | B. He | Ajay Gupta | M. A. Sorocéanu | Hanyi Su | Xin-Kang Tong